European Database on Catheter-directed Treatment of Pulmonary Embolism.

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04037423

Acronym

EuroPE-CDT

Enrollment

145

Registered

2019-07-30

Start date

2019-06-04

Completion date

2022-03-31

Last updated

2023-08-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Pulmonary Embolism

Brief summary

The main goals of EuroPE-CDT is to assess the currently applied catheter-directed treatment (CTD) techniques and strategies in pulmonary embolism (PE) patients and to determine the short term efficacy and safety of this invasive procedure.

Detailed description

This is a prospective (and retrospective, if required data are available), non-interventional, multicenter study. We intend to obtain data on basic patients characteristics, pulmonary embolism severity, catheter-directed treatment procedures and short term outcome. We are planning to include approximately 150-200 patients suitable for analysis by the end of 2020. Anonymized data of consecutive PE patients treated with CTD in European centers will be collected in the database.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

OTHER

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* acute pulmonary embolism * catheter-directed embolectomy

Exclusion criteria

* appropriate data not available

Design outcomes

Primary

Measure	Time frame	Description
Survival	30 days after the procedure	Short-time follow-up

Secondary

Measure	Time frame	Description
Complications	During hospitalisation (estimated 10 days)	Any procedure-related complications, such as: * local hematoma, * hemoptysis, * pulmonary artery injury, * contrast-induced nephropathy, * renal replacement therapy.

Countries

Poland

Outcome results